Monday, July 2, 2018

Getting to Know.. Cochlear Limited

You could have bought stock in Cochlear Limited at the turn of the century for about $10. A few days ago the stock was worth more than $200 a share. Shares of the stock have increased nearly 30 percent in the last year.

Cochlear Limited is the biggest of the three companies that dominate the cochlear implant market. Based in Australia, Cochlear Limited does most of its business in Europe and the U.S. through more than a dozen subsidiaries. It's net revenue was about $110 million last year. With brands like Nucleus and Bah, more than a quarter of a million people have one of its implants. It employs more than 2800 people.

No comments: